Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial biopharma-reporter.com Submitted by Sorin61 t3_z563cl on November 26, 2022 at 12:10 PM in technology 186 comments 13,682
No_Formal_8697 t1_ixzkh82 wrote on November 27, 2022 at 4:59 PM Reply to comment by No_Formal_8697 in Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61 Use nanowire/ particles to selectively target the cells. Bring the battle inside. Permalink Parent 1
Viewing a single comment thread. View all comments